GlaxoSmithKline PLC (
) will begin trading ex-dividend on February 19, 2014. A cash
dividend payment of $0.749616 per share is scheduled to be paid on
April 10, 2014. Shareholders who purchased GSK stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 21.67% increase over the prior quarter.
The previous trading day's last sale of GSK was $55.89,
representing a -0.04% decrease from the 52 week high of $55.91 and
a 27.95% increase over the 52 week low of $43.68.
GSK is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). GSK's current earnings per share, an indicator of a company's
profitability, is $3.54. Zacks Investment Research reports GSK's
forecasted earnings growth in 2014 as 7.12%, compared to an
industry average of -.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to GSK through an Exchange
Traded Fund [ETF]?
The following ETF(s) have GSK as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- FlexShares International Quality Dividend Defensive Index
- FlexShares International Quality Dividend Index Fund (
- FlexShares Morningstar Developed Markets ex-US Factor Tilt
The top-performing ETF of this group is PPH with an increase of
16.92% over the last 100 days. It also has the highest percent
weighting of GSK at 4.87%.